Open angle glaucoma (OAG) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

Posted on
by

Open angle glaucoma (OAG) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

DelveInsight Business Research LLP
DelveInsight’s Open-angle glaucoma (OAG) Market Insights, Epidemiology, and Market Forecast—2030 (7MM) report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of OAG in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

DelveInsight has launched a new report on “Open angle glaucoma (OAG) – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Open angle glaucoma (OAG) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Open angle glaucoma (OAG), historical and forecasted epidemiology as well as the  Open angle glaucoma (OAG) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. According to various studies, it has been estimated approximately 45 million people were affected by Open-angle glaucoma (OAG) worldwide, and by 2020 this number is expected to increase to 58.5 million. Almost half (47%) of these people reside in Asia while 24% are European. The mean prevalence is estimated to be 1.96%. Moreover, women are expected to comprise >55% of those with OAG because of their increased life span as compared to men. 

  2. According to a literature review, the overall prevalence of OAG in individuals 40 years old is 1.86%, owing to the rapidly aging population, the number with OAG will increase by 50% to 3.36 million in 2020.Various studies in Europe estimated prevalence to be around 1–3% in persons 40 years and older. According to the study, the prevalence of OAG in men was double that in women (odds ratio 2.1; 95% CI 1.2, 3.6).

  3. The Tajimi screening study estimated that the prevalence of primary open-angle glaucoma (POAG) in Japanese subjects older than 40 years was 3.9%. The study estimated the prevalence of POAG in Japanese subjects as 3.7%, near to Tajimi study.

Key benefits of the report:

1. Open angle glaucoma (OAG) market report covers a descriptive overview and comprehensive insight of the Open angle glaucoma (OAG) epidemiology and Open angle glaucoma (OAG) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. The Open angle glaucoma (OAG) market report provides insights on the current and emerging therapies.

3. Open angle glaucoma (OAG) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4. The Open angle glaucoma (OAG) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Open angle glaucoma (OAG) market.

Request for sample pages: https://www.delveinsight.com/sample-request/open-angle-glaucoma-market

Open angle glaucoma (OAG): Overview

Open-angle glaucoma (OAG) is a chronic, progressive, and irreversible multifactorial optic neuropathy that is characterized by open angle of the anterior chamber, typical optic nerve head changes, progressive loss of peripheral vision (typical visual field changes) followed by central visual field loss (blindness) for which intraocular pressure (IOP) is an important risk factor.

The key players involved in the Open angle glaucoma (OAG) market:

  1. Ocular Therapeutix, 

  2. Santen Pharmaceutical, 

  3. Laboratorios Sophia, 

  4. Aerie Pharmaceuticals

  5. Bausch & Lomb 

The launch of the emerging therapies is expected to significantly impact the  Open angle glaucoma (OAG) treatment scenario in the upcoming years:-

Drug covered

  1. OTX-TP/ OTX-TIC

  2. Sepetaprost 

  3. PRO-122

  4. Rhopressa

  5. Vyzulta

Request a free sample report @https://www.delveinsight.com/sample-request/open-angle-glaucoma-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Open angle glaucoma (OAG) Patient Share (%) Overview at a Glance

5. Open angle glaucoma (OAG) Market Overview at a Glance

6. Open angle glaucoma (OAG) Disease Background and Overview

7. Open angle glaucoma (OAG) Epidemiology and Patient Population

8. Country-Specific Patient Population of Open angle glaucoma (OAG)

9. Open angle glaucoma (OAG) Current Treatment and Medical Practices

10. Unmet Needs

11. Open angle glaucoma (OAG) Emerging Therapies

12. Open angle glaucoma (OAG) Market Outlook

13. Country-Wise Open angle glaucoma (OAG) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Open angle glaucoma (OAG) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Open angle glaucoma- Epidemiology Forecast to 2030

DelveInsight’s ‘Open angle glaucoma- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Open angle glaucoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/